Courtagen, Scienion Ink Protein Biochip Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Scienion US said today that array firm Courtagen Life Sciences will use Scienion's sciFlexArrayer technology to produce biochips for use with its Avantra Q400 Biomarker Workstation.

Courtagen will use the company's sciFlexArrayer S11 instrument to produce biochips for automated multiplex immunoassays for research and clinical use.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.